Pro Data Export
Optimer Pharmaceuticals Key Statistics
Current Valuation
Dividends and Shares
| Shares Outstanding | 48.02M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | 84.54% |
| Profit Margin Quarterly | 5.13% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 5.675 |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -34.70M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -3.34% |
| Year to Date Stock Returns | 60.11% |
| 1 Year Stock Returns | -6.33% |
| 3 Year Stock Returns | 32.45% |
| 52 Week High | 16.80 |
| 52 Week Low | 8.64 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 6.882M |
| Cash from Investing TTM | 119.29M |
| Cash from Operations TTM | -38.88M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 124.00M |
| Long Term Debt | 0.00 |
| Total Assets | 159.43M |
| Liabilities | 28.62M |
| Shareholders Equity | 130.81M |
| Book Value | 130.81M |
| Book Value Per Share | 2.724 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
OPTR News
Cubist (CBST) Said to Bid $1B for Optimer (OPTR) Before Sales Proceeds - Reuters
Street Insider May 15
Street Insider May 15
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OPTR | 14.49 | +0.06 | +0.42% | 695.87M |
New watchlist
